Join us for this exploration of transcriptional and pathophysiological responses to hypoxia, and of the sensing mechanisms responsible for detection of oxygen level changes in the body.

With ten million individuals afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or preventative measures—are hopeful indicators of progress in this field.

This symposium brings together world-renowned researchers and clinicians to shed light on these recent steps forward in cancer studies. Its primary goal is to contribute to the advancement of new immunotherapeutic and preventive approaches for future cancer vaccines.

Long considered a threat to survival, hypothermia has received a considerable new look and use in clinical settings in the past twenty years. Recent animal and clinical studies have demonstrated the effectiveness of using hypothermia to treat cardiac arrest and offer a promising treatment paradigm for acute ischemic stroke.

Hypothermia: From Threat to Cure, a one-day conference will increase our understanding of the clinical benefits of hypothermia by examining it as an integrated biological response of the organism. This interdisciplinary meeting will first look at current clinical applications of hypothermia in settings such as neurocritical intensive care units, cardiac surgery, and animal experiments. Hypothermia will then be examined through the perspectives of cellular, thermal, and evolutionary biology. Participants will explore evidence found in biological, cellular, and molecular processes such as thermoregulation, energy metabolism, and immunology.